CompletedPhase 2

Observation Study of T-Gel (1%) in Treatment of Adolescent Boys With Hypogonadism

United StatesStarted 2002-08

Plain-language summary

This study is to observe efficacy and safety after T-Gel 1% treatment in delayed puberty adolescents. Subjects who complete this trial may enter a 3 month extension study (UMD-01-090E).

Who can participate

Age range13 Years – 17 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Primary or secondary hypogonadism or constitutional delay in growth and puberty (CDGP) Exclusion Criteria: * Skin intolerance to alcohol or allergy to soy * Generalized skin disease * Contraindication to testosterone or androgen products

Trial details

NCT IDNCT00193661

SponsorSolvay Pharmaceuticals

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2007-03

View on ClinicalTrials.gov More Primary or Secondary Hypogonadism trials